The study found that high Arg-1 expression in tumor tissues correlated with favorable clinicopathological features and longer recurrence-free survival (RFS), while elevated plasma Arg-1 levels were linked to poor clinical outcomes. The gene discussed is ARG1; the disease is neoplasm.